These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 28760898

  • 21. The ABC of Biofilm Drug Tolerance: the MerR-Like Regulator BrlR Is an Activator of ABC Transport Systems, with PA1874-77 Contributing to the Tolerance of Pseudomonas aeruginosa Biofilms to Tobramycin.
    Poudyal B, Sauer K.
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29180529
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
    McCaughey G, McKevitt M, Elborn JS, Tunney MM.
    J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
    [Abstract] [Full Text] [Related]

  • 27. Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin.
    Eckert R, Brady KM, Greenberg EP, Qi F, Yarbrough DK, He J, McHardy I, Anderson MH, Shi W.
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3833-8. PubMed ID: 16940063
    [Abstract] [Full Text] [Related]

  • 28. Treatment with the Pseudomonas aeruginosa Glycoside Hydrolase PslG Combats Wound Infection by Improving Antibiotic Efficacy and Host Innate Immune Activity.
    Pestrak MJ, Baker P, Dellos-Nolan S, Hill PJ, Passos da Silva D, Silver H, Lacdao I, Raju D, Parsek MR, Wozniak DJ, Howell PL.
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30988141
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. In vitro activity of clarithromycin in combination with other antimicrobial agents against biofilm-forming Pseudomonas aeruginosa strains.
    Kádár B, Szász M, Kristóf K, Pesti N, Krizsán G, Szentandrássy J, Rókusz L, Nagy K, Szabó D.
    Acta Microbiol Immunol Hung; 2010 Sep; 57(3):235-45. PubMed ID: 20870595
    [Abstract] [Full Text] [Related]

  • 32. Susceptibility of Pseudomonas aeruginosa Dispersed Cells to Antimicrobial Agents Is Dependent on the Dispersion Cue and Class of the Antimicrobial Agent Used.
    Chambers JR, Cherny KE, Sauer K.
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971863
    [Abstract] [Full Text] [Related]

  • 33. Pharmacological Inhibition of the Pseudomonas aeruginosa MvfR Quorum-Sensing System Interferes with Biofilm Formation and Potentiates Antibiotic-Mediated Biofilm Disruption.
    Maura D, Rahme LG.
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923875
    [Abstract] [Full Text] [Related]

  • 34. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients.
    García-Castillo M, del Campo R, Baquero F, Morosini MI, Turrientes MC, Zamora J, Cantón R.
    Clin Microbiol Infect; 2011 May; 17(5):704-11. PubMed ID: 20673272
    [Abstract] [Full Text] [Related]

  • 35. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A, Lajoie B, El Hage S, Baziard G, Roques C.
    Antimicrob Agents Chemother; 2015 Dec 28; 60(3):1676-86. PubMed ID: 26711774
    [Abstract] [Full Text] [Related]

  • 36. Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin.
    Müller L, Murgia X, Siebenbürger L, Börger C, Schwarzkopf K, Sewald K, Häussler S, Braun A, Lehr CM, Hittinger M, Wronski S.
    J Antimicrob Chemother; 2018 Oct 01; 73(10):2762-2769. PubMed ID: 29982453
    [Abstract] [Full Text] [Related]

  • 37. Escherichia coli exopolysaccharides disrupt Pseudomonas aeruginosa biofilm and increase its antibiotic susceptibility.
    Wan C, Ju X, Xu D, Ou J, Zhu M, Lu G, Li K, Jiang W, Li C, Hu X, Tian Y, Niu Z.
    Acta Biomater; 2024 Sep 01; 185():215-225. PubMed ID: 39067645
    [Abstract] [Full Text] [Related]

  • 38. Biofilm Antimicrobial Susceptibility Increases With Antimicrobial Exposure Time.
    Castaneda P, McLaren A, Tavaziva G, Overstreet D.
    Clin Orthop Relat Res; 2016 Jul 01; 474(7):1659-64. PubMed ID: 26797908
    [Abstract] [Full Text] [Related]

  • 39. Marine-derived quorum-sensing inhibitory activities enhance the antibacterial efficacy of tobramycin against Pseudomonas aeruginosa.
    Busetti A, Shaw G, Megaw J, Gorman SP, Maggs CA, Gilmore BF.
    Mar Drugs; 2014 Dec 24; 13(1):1-28. PubMed ID: 25546516
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.